StockData
Tvardi Therapeutics, Inc. logo

Tvardi Therapeutics, Inc. (TVRD) stock

TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.99+0.04 (+4.57%)

Close on Nov 20, 2026Market cap $13.20MP/E –Yield 0.00%

Tvardi Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2021 it was $23.03M.

Annual gross profit

PeriodPeriod endValueChange
FY2021Dec 31, 2021$23.03M–

More Tvardi Therapeutics figures

See a number that looks wrong?